Labcorp to Speak at UBS Global Healthcare Virtual Conference
May 18 2021 - 6:59AM
Business Wire
Labcorp (NYSE: LH), a leading global life sciences company,
today announced that members of the executive management team will
participate in a virtual fireside chat at the UBS Global Healthcare
Virtual Conference on Monday, May 24 at 3:00 p.m. ET.
A live webcast of the presentation will be available via the
Investor Relations section of the company’s website at
www.Labcorp.com and archived for replay.
About Labcorp Labcorp is a leading global life sciences
company that provides vital information to help doctors, hospitals,
pharmaceutical companies, researchers, and patients make clear and
confident decisions. Through our unparalleled diagnostics and drug
development capabilities, we provide insights and accelerate
innovations to improve health and improve lives. With more than
70,000 employees, we serve clients in more than 100 countries.
Labcorp (NYSE: LH) reported revenue of $14.0 billion in FY2020.
Learn more about us at www.Labcorp.com or follow us on LinkedIn and
Twitter @Labcorp.
Labcorp Cautionary Statement Regarding Forward-Looking
Statements This press release contains forward-looking
statements, including but not limited to statements with respect to
the impact of various factors on operating and financial results
and the opportunities for future growth.
Each of the forward-looking statements is subject to change
based on various important factors, many of which are beyond the
Company’s control, including without limitation, the impact of the
COVID-19 pandemic on our business and financial condition as well
as on general economic, business, and market conditions,
competitive actions and other unforeseen changes and general
uncertainties in the marketplace, changes in government
regulations, including healthcare reform, customer purchasing
decisions, including changes in payer regulations or policies,
other adverse actions of governmental and third-party payers, the
Company’s satisfaction of regulatory and other requirements,
patient safety issues, changes in testing guidelines or
recommendations, federal, state, and local governmental responses
to the COVID-19 pandemic, adverse results in material litigation
matters, failure to maintain or develop customer relationships, our
ability to develop or acquire new products and adapt to
technological changes, failure in information technology, systems
or data security, changes in business conditions and the economy in
general, adverse weather conditions, the number of revenue days in
a financial period, employee relations, personnel costs, and effect
of exchange rate fluctuations. These factors, in some cases, have
affected and in the future (together with other factors) could
affect the Company’s ability to implement the Company’s business
strategy and actual results could differ materially from those
suggested by these forward-looking statements. As a result, readers
are cautioned not to place undue reliance on any of our
forward-looking statements.
The Company has no obligation to provide any updates to these
forward-looking statements even if our expectations change. All
forward-looking statements are expressly qualified in their
entirety by this cautionary statement. Further information on
potential factors, risks and uncertainties that could affect
operating and financial results is included in the Company’s most
recent Annual Report on Form 10-K and subsequent Forms 10-Q,
including in each case under the heading RISK FACTORS, and in the
Company’s other filings with the SEC.
# # #
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210518005589/en/
Labcorp Contacts: Investors: Chas Cook — 336-436-5076
Investor@Labcorp.com
Media: Christopher
Allman-Bradshaw — 336-436-8263 Media@Labcorp.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Apr 2023 to Apr 2024